ANI PHARMACEUTICALS INC
ANIP·00182C103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
ANIP (ANI PHARMACEUTICALS INC) is held by 145 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($211.3M), VANGUARD CAPITAL MANAGEMENT LLC ($63.3M), STATE STREET CORP ($59.3M). Net institutional sentiment: Mixed.
145
Holders
(12 Elite)
$1.3B
Total Value
54% (149)
Consensus
81 buying - 68 selling
13F: Insider & Congress:
Who's Trading
InsiderCMCook MeredithSell $41KJul 13, 2026
InsiderCPCAREY STEPHEN P.Sell $240KJun 29, 2026
InsiderCMCook MeredithSell $41KJun 12, 2026
InsiderCMCook MeredithSell $39KMay 13, 2026
InsiderRARowland Thomas AndrewSell $36KMay 12, 2026
InsiderCMCook MeredithSell $39KApr 13, 2026
InsiderMCMutz ChristopherSell $227KMar 13, 2026
InsiderCMCook MeredithSell $36KMar 13, 2026
ActivistICIntegrated Core Strategies (US) LLC0.2%Nov 13, 2025
Showing 1-20 of 159
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer